Hemoglobinopathy treatment drugs encompass a range of pharmaceutical and biotech solutions designed to manage genetic blood disorders such as sickle cell disease and thalassemia. These therapies include small-molecule agents like hydroxyurea, novel biologics targeting erythropoiesis, and cutting-edge gene therapies that correct the underlying hemoglobin mutations. https://zippy-goat-z7kvvr.mystrikingly.com/blog/hemoglobinopathy-treatment-drugs-markettrends-driven-by-rising-disease